Open session Open full presentation page
Oral Presentation

Investigation of immune responses to SLA-derived antigens presented on HLA class II

Presenter
Ken Kawada (JP)

Nagasaki University ยท Nagasaki

Profile

Authors

Ken Kawada1,2, Kenta Iwasaki3, Susumu Tomono4, Yuko Miwa3, Masato Shizuku1, Satoshi Ashimine1, Kohei Ishiyama1, Sachiko Takamura4, Ryoichi Imamura2, Takaaki Kobayashi1

Affiliations

1 Aichi Medical University School of Medicine
2 Nagasaki University
3 Aichi Medical University School of Medicine
4 Aichi Medical University School of Medicine

Abstract

Background/Objectives: In xenotransplantation, identifying the xenoantigens that trigger potent indirect T-cell responses remains a critical challenge, whereas in allotransplantation, these responses and the resulting de novo donor-specific antibodies (DSAs) are well-known barriers to long-term survival. Although ten-gene-modified pigs have entered clinical study phases, the immunological significance of swine T-cell epitopes has not been fully elucidated. This study aimed to identify swine-derived peptide epitopes presented by human HLA class II molecules using ligandome analysis to clarify their role in xenograft immunity.
Methods: CD14+ monocytes were purified from human peripheral blood and differentiated into dendritic cells by adding IL-4, GM-CSF, IL-1β, and TNF-α in the presence of irradiated porcine liver-derived endothelial cell triple-gene knockout (GGTA1/CMAH/β4galNT2). Immunoprecipitation was performed using anti-HLA-DR antibodies, followed by mass spectrometry via nanoLC-qTOF/MS/MS to comprehensively analyze the presented peptides. The obtained peptides were synthesized and co-cultured with PBMCs from healthy individuals, and the production of IFN-γ and IL-21 was measured using the ELISPOT assay.
Results: On average, 608 swine-derived peptides corresponding to 197 antigens were identified. Among them, three peptides derived from swine leukocyte antigen (SLA), FIAVGYDDTQFVR (SLA-2), GVSETVFLPR (SLA-DRA1), and FDSDVGSFR (SLA-DQB1), were consistently detected across different samples. When we confirmed the ELISPOT response of peptides derived from the obtained SLA-derived peptides in healthy human PBMCs, T-cell responses were observed in multiple samples, although individual differences were noted.
Discussion: While some DSAs pose a high risk due to cross-reactivity with SLA, there is a possibility that porcine organ transplantation could induce novel indirect T-cell responses against SLA even in DSA-negative recipients. Our findings show that SLA-derived peptides are presented by human HLA class II and recognized by T cells, suggesting their role in xenograft immunity. These epitopes may be targets for genome editing to improve graft survival.